Related Experiment Video
Updated: Sep 27, 2025
13:24
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11.9K
Evidence-Based Selection, Development, and Testing of a Tailored Strategy to Improve Standardized Structured
Julie E M Swillens1, Quirinus J M Voorham2, Iris D Nagtegaal3
1From the Scientific Center for Quality of Healthcare, Radboud Institute for Health Sciences (Swillens, Hermens).
Archives of Pathology & Laboratory Medicine
|April 13, 2022
Summary
Implementing a multifaceted strategy significantly improved standardized structured reporting (SSR) usage in oncologic pathology. This approach, using targeted interventions, enhances diagnostic accuracy and patient care.
Area of Science:
- Pathology
- Medical Informatics
- Oncology
Background:
- Standardized structured reporting (SSR) enhances diagnostic completeness, treatment decisions, and patient outcomes in pathology.
- SSR template usage is recommended in oncology guidelines, but implementation varies due to identified barriers and facilitators.
Purpose of the Study:
- To develop and test an evidence-based, multifaceted strategy to improve SSR implementation in oncologic pathology.
- The strategy was tailored to address specific impeding and facilitating factors identified in previous research.
Main Methods:
- A six-element strategy was developed based on barrier/facilitator analysis, literature review, and expert consultation.
- Elements included a renewed website, e-learning, communication manual, improved feedback mechanisms (Feedback Button, FAQs), update information sheets, and monthly audit discussions.
- The strategy was tested in a pilot setting in collaboration with PALGA.
Main Results:
- A significant increase of 12.4% in SSR usage was observed in the test laboratories.
- E-learning modules and the 'Feedback Button' were identified as the most feasible and effective components.
- Increased awareness of all strategy elements is needed for broader impact.
Conclusions:
- The developed multifaceted strategy shows promise for improving SSR implementation in oncologic pathology.
- Further optimization and nationwide distribution are planned to evaluate effectiveness and feasibility in a broader setting.
